Doximity (DOCS) Stock Forecast & Price Target

Doximity Inc. reported a 10% year-over-year increase in revenues for FY3Q26, reaching $185.1 million, outperforming both guided and consensus estimates, indicating strong financial momentum. The company exhibited robust growth among existing customers, particularly in its top 20 clients, with notable expansion in higher-tier spending as evidenced by a 10% year-over-year increase in customers investing over $500,000 annually. Additionally, unique active users and engagement metrics reached record levels, reflecting the platform's effectiveness and increasing utilization of its comprehensive suite of services.

Doximity Inc. experienced a decline in gross margins, which decreased to 91.5%, showing a 40 basis points drop from the previous quarter and an alarming 180 basis points decline year-over-year. The company’s forecast for FYQ4 appears weaker than expected, with anticipated growth of only 4% year-over-year, largely attributed to industry-wide policy headwinds affecting client budget decisions, particularly among pharmaceutical clients. Additionally, the net revenue retention (NRR) rate for the top 20 customers has decreased to 112%, down from 117% last year and 118% the previous quarter, indicating potential challenges in maintaining existing client relationships and revenue growth.